Organic selenized yeast enriched with selenoamino acids or inorganic sodium selenate (Na2SeO4) was administered per os three times weekly as a drench for 133 d to previously unsupplemented cows that were grazing low Se pastures. Treatment groups received the equivalent of 2 or 4 mg of Se/d of either supplement form. Control cows did not receive a drench. Samples of blood and milk were collected regularly throughout the trial. Selenium concentrations in blood, milk, casein, and liver and glutathione peroxidase activity in blood and liver are reported as responses per milligram of Se intake. Mean blood Se concentrations in treated cows increased steadily and, by d 133, were 4.7 to 8.8 times that in controls. Selenized yeast was 2 to 3 times more effective than was Na2SeO4, and low Se intakes were 27% more efficient per milligram of Se administered than were high Se intakes at increasing milk Se concentration. Casein Se content mirrored that of milk; among all treated and control cows and throughout the trial, the molar ratio of Se in casein as a percentage of the Se in whole milk was constant at 71 +/- 1.2%. The Se concentration in liver biopsies taken on d 133 was indicative of total Se intake during the trial and ranged from 920 to 3920 nmol of Se/kg of fresh weight. These results demonstrate the differing efficacy of organic and inorganic Se dietary supplements to increase dairy cow Se status and to enhance Se content of milk and casein.
Phosphorus (P) fertilisers are an essential input for the economic production of legume-based pastures in New Zealand (NZ) and Australia, but they often contain some unwanted elements that can contaminate the soil, thereby creating potential risks to the health of grazing animal, food quality, and soil quality. Fluorine (F) and cadmium (Cd) are considered to be the elements of most concern. Incidences of F toxicity (from direct ingestion of fertiliser), and accumulation of Cd in offal products above the maximum permissible concentration (MPC) set by the food authorities, have been reported in NZ. Similarly, Cd concentrations in some food grains may exceed the newly proposed MPCs by the Australian and New Zealand Food Authority. Cadmium and F continue to accumulate in the topsoils of NZ and Australian pastures as a result of P fertiliser use. The mobility of both these elements in soils is low and is similar to that of P. Risk of ground water contamination from F and Cd applied to most NZ pastures is low. The plant uptake of these elements, especially F, is also low in most pastoral soils. Cadmium accumulates mainly in liver and kidney of grazing animals mostly through herbage ingestion, whereas F accumulates mainly in the bones of these animals, mostly through soil ingestion. Soil ingestion is highest during the wetter winter months and at high stocking rates. Models have been developed to assess the impact of fertiliser use on the potential risks associated with F and Cd accumulation in soils. Measures to control F and Cd accumulation in soils, plants, and grazing animals are presented and future research needs are identified.
The membrane spanning enzyme gamma-glutamyl transpeptidase (gamma-GT; EC 2.3.2.2) catalyses the breakdown of the tripeptide glutathione and uses free amino acids (AA) to form gamma-glutamyl transpeptidase (GT) AA that become transported into cells and converted back into free AA. gamma-Glutamyl transpeptidase activity has been shown to be important for mammary AA uptake in rodent systems, and while gamma-GT activity is high in lactating bovine mammary tissue, the role of this enzyme in milk protein synthesis of the ruminant has not been defined. The present study shows that gamma-GT activity in the ovine mammary gland, like that of rodents, increases during pregnancy and peaks early in lactation. Acivicin, a well-known inhibitor of gamma-GT, decreased gamma-GT activity in acini isolated from the ovine mammary gland and did not have secondary toxicity effects on cell viability or the uptake of radiolabeled amino-isobutyric acid. Isolated ovine acini were incubated in the presence of radiolabeled leucine, and incorporation of label into secreted protein increased during incubation. Incubation of acini with acivicin decreased milk protein secretion by 75%, indicating that gamma-GT plays an important role in milk protein production in the ruminant. Acivicin did not inhibit secretion of specific caseins but caused a global decrease in individual proteins suggesting that gamma-GT may be responsible for providing a complement of AA for milk protein synthesis.
Infusion of [ 35 S]-labelled cysteine into the jugular of Romney sheep of different ages was used to estimate the extent of combined cysteine and cystine (cyst(e)ine) and glutathione (GSH) interchange in various tissues, including skin, and to measure whole body irreversible loss rates (1LR) for cyst(e)ine. The studies were undertaken at Palmerston North, New Zealand during 1990 and 1991.Reverse phase HPLC using a fluorigenic reagent, 7-fluoro-2,1,3-benzoxadiazole-4-sulphonate (SBD-F) was used for the simultaneous determination of thiols (cysteine and GSH) in whole blood (bound and free fractions), liver, kidney, small intestine, muscle, pancreas and skin. The appearance of [ 35 S]-label in thiol compounds and their oxidation products was determined by ion-exchange HPLC. Specific radioactivities (SRA) for cyst(e)ine and GSH derived from this data showed equivalence for cysteine and GSH SRAs in all tissues, except for whole blood, indicating rapid withintissue interconversion between these thiols. In whole blood, however, the very low SRA for GSH (< 4 DPM/nmol) compared to cyst(e)ine (250 DPM/nmol) indicated markedly slower or negligible exchange with red blood cell GSH, and hence little inter-organ transport of [ 35 S]-label as GSH.Close infusion of [ 35 S]cysteine into a defined patch of skin and collection of the venous outflow permitted direct in vivo measurement of the proportional uptake of cysteine by the skin. Results indicated considerable variation in the uptake of cysteine per se (20-40 %) but no, or very little, oxidation of cysteine in the skin and no net export of GSH.The combination of whole body, tissue and skin specific studies of [ 35 S]-labelled cysteine metabolism quantitatively confirmed the very high proportion of circulating cyst(e)ine in sheep which is directed to skin and wool protein synthesis alone, and highlighted those aspects of this metabolism which are of most importance to wool production.
The utilisation of essential amino acids (EAA) by the mammary gland of lactating dairy cows fed fresh forages was studied to provide basic information useful in designing strategies to increase the production of milk protein from pasture-fed dairy cows. The relationship between the flux of EAA in the whole body and their uptake by the mammary gland was determined in four cows in early lactation (length of time in milk 44 (SD 14·5) d) producing 21 (SD 4·0) kg milk/d. The cows were maintained in metabolism stalls and fed fresh perennial ryegrass (Lolium perenne) and white clover (Trifolium repens) pasture ad libitum or restricted to 75 % ad libitum intake. The whole-body fluxes of amino acids (AA) were measured using an arterio-venous infusion of universally 13 C-labelled AA. Whole-body fluxes of fourteen AA were estimated. Isotope dilution indicated that mammary utilisation accounted for one-third of the whole-body flux of EAA, with individual AA ranging between 17 and 35 %. Isoleucine, leucine, valine and lysine were the EAA with the greatest partitioning towards the mammary gland (up to 36 % of the whole-body flux), which could reflect a potentially limiting effect on milk protein synthesis. In the case of AA with low partitioning to the mammary gland (for example, histidine), it is suggested that non-mammary tissues may have priority over the mammary gland and therefore the supply of this AA may also limit milk protein synthesis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.